Covid-19: Critical Quality Measures for Pharmaceutical Production

episode

The Qualitalks Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Planning Commission Work Session - Sep 17, 2026 4h 39m · 17 Sep 2026 · Loudoun County Planning Commission

Report any issue

Source

Recorded03 May 2020

Publisheranchor.fm ↗

Handlerec:11442022

Show notes

Due to the COVID-19 situation, governments across the world initiated lockdown and quarantines. The lockdowns have a severe impact on pharmaceutical manufacturing across the globe. Some of that include: Shortage of raw materials Personnel deficiency Export bans Severe financial damage All those obstacles lead to a unique manufacturing environment, which may lead to quality deficiencies. During their talk, Hitendrakumar Shah, the CEO of NADH+ GXP Compliance Services, shared with Yan Kugel his suggestions on how to avoid quality issues during manufacturing, throughout that particular time. You can watch the podcast in a video format on www.qualistery.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in